Precision Biologics, Inc.
Records under this name other than the patents Precision Biologics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 24 patents it holds.
Showing 1 to 10 of 10 · Back to Precision Biologics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,763,720 | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Term ended Term ended Aug 22, 2026 · From the USPTO record | Term ended | Term ended Aug 22, 2026 | From the USPTO record |
| US 11,401,341 | Recombinant Monoclonal Antibodies and Corresponding Antigens for Colon and Pancreatic Cancers Lapsed on the fee record Ended Aug 2, 2026 · Low confidence | Lapsed on the fee record | Ended Aug 2, 2026 | Low confidence |
| US 10,364,295 | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Term ended Term ended Jul 9, 2026 · From the USPTO record | Term ended | Term ended Jul 9, 2026 | From the USPTO record |
| US 7,314,622 | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Term ended Term ended Apr 14, 2026 · From the USPTO record | Term ended | Term ended Apr 14, 2026 | From the USPTO record |
| US 9,605,077 | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Term ended Ended no later than Apr 14, 2026 · From the USPTO record | Term ended | Ended no later than Apr 14, 2026 | From the USPTO record |
| US 11,078,245 | Colon and Pancreas Cancer Peptidomimetics Lapsed on the fee record Ended Aug 3, 2025 · Medium confidence | Lapsed on the fee record | Ended Aug 3, 2025 | Medium confidence |
| US 9,034,588 | Monoclonal Antibody Therapy for Pancreas Cancer Term ended Term ended Apr 14, 2025 · Medium confidence | Term ended | Term ended Apr 14, 2025 | Medium confidence |
| US 8,470,326 | Monoclonal Antibody Therapy for Pancreas Cancer Term ended Term ended Jul 26, 2022 · Medium confidence | Term ended | Term ended Jul 26, 2022 | Medium confidence |
| US 9,592,290 | Monoclonal Antibody Therapy for Pancreas Cancer Term ended Term ended Mar 15, 2022 · Medium confidence | Term ended | Term ended Mar 15, 2022 | Medium confidence |
| US 11,001,641 | Monoclonal Antibody Therapy for Pancreas Cancer Term ended Term ended Mar 15, 2022 · Medium confidence | Term ended | Term ended Mar 15, 2022 | Medium confidence |